Chronically elevated circulating free fatty acids (FFA) contribute to β-cell dysfunction and thus to the onset of obesity-driven type 2 diabetes (T2DM). Prolonged β-cell exposure to FFA is associated with reduced glucose-stimulated insulin secretion (GSIS), alterations in β-cell transcriptional identity, and apoptosis. However, the mechanisms that contribute to the demise of β-cells under lipotoxic conditions have yet to be fully elucidated. Increasing evidence suggests that aberrant release of extracellular vesicles (EV) contribute to the pathogenesis of β-cell failure in T2DM. However, what remains to be deciphered is the role of β-cell-derived EV in lipotoxicity-mediated β-cell failure. We set out to test the hypothesis that lipotoxicity-mediated β-cell dysfunction is mediated in part by paracrine release of ‘toxic’ β-cell-derived EV. To address this, MIN6 β-cells were exposed to palmitate (0.5 mM, 24h) and EV were isolated using differential ultracentrifugation to yield palmitate (PAL) EV (vs. control (CTL) EV). Nanoparticle Tracking Analysis (NTA) revealed a significant increase in PAL EV concentration (~1.5 fold vs. CTL EV) with a reduction in average particle size (CTL EV = 121 nm vs. PAL EV = 75 nm). β-cell functional assessment of mouse islets exposed to PAL EV (48h) resulted in significant suppression of GSIS (~3.4 fold decrease in stimulation index). Global transcriptomic analysis was assessed using RNA-Seq on islets exposed to PAL EV. Over 900 genes were differentially upregulated and ~450 genes downregulated upon PAL EV exposure (p<.05, FC>1.5). Genes upregulated with PAL EV encoded for KEGG pathways regulating protein digestion/absorption, ECM-receptor interaction, and PI3K/Akt signaling, while downregulated genes encode for pathways regulating glycolysis and protein processing in ER (FDR<.05). These data suggest the novel relevance of β-cell-derived EV in free fatty acid-induced β-cell failure in T2DM.

Disclosure

T. K. Her: None. M. Brown: None. A. Matveyenko: None. N. Javeed: None.

Funding

National Institutes of Health (R01DK098468, T32HL105355)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.